Expected individual benefit of prophylactic platelet transfusions in hemato‐oncology patients based on bleeding risks

BACKGROUND: Prophylactic platelet transfusions prevent bleeding in hemato‐oncology patients, but it is unclear how any benefit varies between patients. Our aim was to assess if patients with different baseline risks for bleeding benefit differently from a prophylactic platelet transfusion strategy....

Descripción completa

Detalles Bibliográficos
Autores principales: Cornelissen, Loes L., Caram‐Deelder, Camila, Fustolo‐Gunnink, Susanna F., Groenwold, Rolf H. H., Stanworth, Simon J., Zwaginga, Jaap Jan, van der Bom, Johanna G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Transfusion Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518514/
https://www.ncbi.nlm.nih.gov/pubmed/34263930
http://dx.doi.org/10.1111/trf.16587

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518514/
https://www.ncbi.nlm.nih.gov/pubmed/34263930
http://dx.doi.org/10.1111/trf.16587

Ejemplares similares